Skip to main content

RadNet, Inc. (RDNT)

Stock NASDAQ

$69.71

+0.20 (+0.29%)

Delayed quote.

Price history

Daily close
RDNT daily closing price, Nov 24, 2025 to Nov 20, 2026 Closed at $84.48 on Nov 24, 2025 and $69.71 on Nov 20, 2026, a change of -17.48%. Range $51.87 to $84.48.
Daily closes, Nov 24, 2025 to Nov 20, 2026 (250 trading days).
Start
$84.48
Latest close
$69.71
Period change
-17.48%
Period low
$51.87
Period high
$84.48

Key metrics

Market cap
$5.49B
Volume
594.2K
Average volume
701.0K
52-week range
$50.82 – $85.84
Beta
1.40
Last dividend
—
EPS (TTM)
-$0.29
P/E ratio
-285.40
Revenue (TTM)
$2.38B
Net income (TTM)
-$22.38M
Total assets
$4.28B
Total debt
$2.17B
Cash and equivalents
$750.61M

Key financials (trailing twelve months).

Company profile

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
CEO
Howard G. Berger
Employees
9,060
Headquarters
Los Angeles, CA, US
IPO date
1997-01-03

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Revenue$2.04B$1.83B$1.62B
Gross profit$90.80M$249.12M$221.39M
Operating income$90.80M$104.62M$98.70M
EBITDA$253.95M$262.55M$292.79M
Net income-$18.65M$2.79M$3.04M
Diluted EPS-$0.25$0.04$0.05
Balance sheet
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Cash and equivalents$767.22M$740.02M$342.57M
Total assets$3.76B$3.29B$2.69B
Total liabilities$2.40B$2.15B$1.88B
Total debt$1.86B$1.73B$1.49B
Shareholders’ equity$1.09B$902.31M$630.70M
Cash flow statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Operating cash flow$298.82M$233.02M$220.86M
Capital expenditure-$213.25M-$188.07M-$176.60M
Free cash flow$85.57M$44.95M$44.26M

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Revenue$638.26M$622.72M$575.63M$547.71M$522.87M$498.23M
Gross profit$85.88M$88.08M-$16.39M$75.93M$72.49M$69.14M
Operating income$30.26M$39.47M-$16.39M$35.08M$32.69M$30.88M
EBITDA$95.20M$90.30M$29.80M$79.90M$77.43M$77.04M
Net income$4.15M$7.53M-$33.47M-$597.0K$5.42M$14.45M
Diluted EPS$0.05$0.10-$0.43-$0.01$0.07$0.19
Balance sheet
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Cash and equivalents$750.61M$726.27M$455.34M$767.22M$804.72M$833.15M
Total assets$4.28B$4.23B$3.89B$3.76B$3.67B$3.51B
Total liabilities$2.84B$2.83B$2.53B$2.40B$2.35B$2.34B
Total debt$2.17B$2.18B$1.93B$1.86B$1.85B$1.90B
Shareholders’ equity$1.12B$1.10B$1.08B$1.09B$1.06B$932.31M
Cash flow statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Operating cash flow$90.57M$87.76M$78.97M$84.16M$52.83M$120.35M
Capital expenditure-$55.51M-$56.28M-$69.93M-$315.03M-$60.45M-$52.94M
Free cash flow$35.06M$31.48M$9.04M-$230.86M-$7.62M$67.41M